Reglan® Injury Cases | Reglan Lawsuit | Drug Injuries

Long-term use of Reglan® has been linked to the development of tardive dyskinesia (TD). TD, a permanent and severe condition, affects the central nervous system and leads to involuntary, repetitive movements of the face and extremities.  There is no cure or effective treatment for the condition. However, the symptoms may be reduced or eliminated if the patient stops taking Reglan for gastrointestinal problems.

Reglan®, also called Metoclopramide, is a prescription drug commonly prescribed to treat gastrointestinal disorders. The medication is available in the form of tablets, oral disintegrating tablets, oral solutions, and injections.

Reglan® is approved for short-term use only, in periods of no longer than three months. However, many patients have been prescribed the medication for a year or more.  In February 2009, the Food and Drug Administration (FDA) announced a black box warning for Reglan® concerning the dangers of both long-term and high dose use, cautioning users of the drug's link to TD. There is currently no effective treatment for the disorder.  So-called “Black Box Warnings” are the strongest such advisories the FDA can order.  In addition to the black box warning, the FDA is requiring manufacturers to implement a risk evaluation and mitigation strategy so that patients are provided with a medication guide that explains the risk of tardive dyskinesia with chronic metoclopramide treatment.

It is estimated that more than two million people in the United States use products containing metoclopramide.

Symptoms of Tardive Dyskinesia

• Facial grimacing, rapid eye movements, and rapid eye blinking
• Involuntary movements of the jaw, tongue or lips  (lip smacking, grimacing, tongue protrusion, puckering and pursing of the lips)
• Rapid, involuntary movements of the hands, fingers, arms, legs, torsp, and shoulders
• Elderly women and people who have taken Reglan at high doses and for an extended period of time (three months or longer) are most at risk of developing tardive dyskinesia.

If you or a loved one has developed tardive dyskinesia or suffered another injury after taking Reglan®, you need to act quickly.  The drug maker and others may be liable for your injuries. Contact SMSH today for free review of your possible Reglan® injury case. You can reach us by calling 1-800-673-1651 or completing the case inquiry form on this page.